The American Society for Biochemistry and Molecular Biology (ASBMB) is warning that a proposed rule from the White House Office of Management and Budget (OMB) could restructure how federal research funding flows to investigators and institutions.

The proposal, flagged by ASBMB, targets the administrative and regulatory framework that governs federal grants. For R&D managers at universities and independent institutes, any change at the OMB level matters: the office sets the uniform guidance that dictates indirect cost recovery, effort reporting, subaward monitoring and audit requirements across agencies such as NIH, NSF and DOE. A rewrite of those rules touches every grant application, every budget justification and every post-award compliance workload in the portfolio.

ASBMB did not mince words about the stakes. The society, which represents thousands of biochemistry and molecular biology researchers, many of whom depend on NIH grants, argues the proposed changes would affect the research enterprise broadly rather than a single discipline. Federal research funding currently represents tens of billions of dollars annually in life sciences alone, and a shift in how those funds are administered — not just how much is appropriated — can move real dollars between direct science and institutional overhead.

What the rule covers

At issue is OMB's authority over circulars and uniform guidance that most non-federal entities must follow when they accept federal money. Past revisions to these rules have produced measurable changes in practice: the 2014 uniform guidance consolidation altered procurement thresholds and raised the single-audit threshold to $750,000, directly reducing administrative burden for smaller awards. Any new proposal in this space would similarly translate into concrete changes for grant offices — in how institutions calculate facilities and administrative rates, how they document cost sharing, and how they handle equipment purchases and personnel charges.

For laboratory leaders, the practical questions are immediate. Would revised guidance change reimbursement rates for facilities and administration, shifting the balance of institutional support? Would new compliance conditions add reporting workload to already strained sponsored research offices? Would the rule alter treatment of research misconduct, foreign influence disclosures or financial conflicts of interest — areas OMB has revisited in prior rulemakings?

ASBMB's warning also lands in a funding environment that researchers already describe as tight. Success rates at NIH hover near historic lows, and multiple principal investigators have reported that any administrative rule change that complicates award management effectively cuts productive lab time. Societies often take positions on such proposals because member surveys consistently rank administrative burden among the top non-financial threats to research productivity.

The comment process matters

Federal rulemaking runs through notice-and-comment. OMB publishes proposed revisions in the Federal Register, and stakeholders — universities, scientific societies, individual investigators — can submit formal comments before a final rule issues. Historically, comment volume has shaped outcomes: agency proposals on grant conditions have been modified or withdrawn after coordinated responses from research organizations. ASBMB's public flagging of the proposal suggests the society intends to mobilize its membership during the comment window, a strategy that has influenced prior uniform guidance revisions.

R&D managers should track three things. First, the exact text of the proposal in the Federal Register, once located, will specify which sections of uniform guidance OMB proposes to change. Second, comment deadlines are typically 30 to 60 days from publication, leaving little time for institutions to coordinate institutional responses. Third, implementation timelines in final rules usually include transition periods, but comptrollers and grant administrators need lead time to update systems and policies.

For portfolio planning, the uncertainty itself carries cost. Institutions negotiating indirect cost rates with the federal government, or planning multi-year project budgets, face a moving regulatory baseline. Some may delay equipment purchases or hiring decisions until the rule's final shape becomes clear.

The proposal now moves through the regulatory process, and researchers, universities and scientific societies will have their say before any final rule determines how the next generation of federal grants is administered.

Note: This analysis is based on ASBMB's initial report on the proposed rule; readers should consult the Federal Register for the full regulatory text and comment deadlines.